Exagen (XGN) Amortization of Deferred Charges (2018 - 2026)
Exagen (XGN) reported Amortization of Deferred Charges of $133000.0 for Q1 2026, up 216.67% on a YoY basis from $42000.0 in Q1 2025, and up 1.53% quarter-over-quarter from $131000.0 in Q4 2025.
Exagen (XGN) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends
Exagen has reported Amortization of Deferred Charges for 9 years, with the latest figure at $133000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 216.67% year-over-year to $133000.0; the trailing twelve-month figure through Mar 2026 stood at $469000.0 (up 194.97% YoY), and the FY2025 full-year result was $378000.0, up 145.45% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $133000.0, up from $131000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $333000.0 in Q3 2022, with the low at -$25000.0 in Q3 2024.
- Historically, Amortization of Deferred Charges has averaged $92882.4 across 5 years, with a median of $79000.0 in 2025.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 932.5% — and 2024, when it sank 136.76%.
- Exagen's Amortization of Deferred Charges stood at $140000.0 in 2022, then tumbled by 50.71% to $69000.0 in 2023, then sank by 39.13% to $42000.0 in 2024, then soared by 211.9% to $131000.0 in 2025, then gained by 1.53% to $133000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $133000.0 (Q1 2026), $131000.0 (Q4 2025), and $126000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133,000.00 |
| Mar 31, 2026 | 133,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 42,000.00 |
| Dec 31, 2024 | 42,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 69,000.00 |
| Dec 31, 2023 | 69,000.00 |